Patent details

EP2242773 Title: MONOCLONAL ANTIBODIES FOR TUMOR TREATMENT

Basic Information

Publication number:
EP2242773
PCT Application Number:
IL2009000153
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097110381
PCT Publication Number:
WO2009101611
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MONOCLONAL ANTIBODIES FOR TUMOR TREATMENT
French Title of Invention:
ANTICORPS MONOCLONAUX POUR LE TRAITEMENT DE TUMEURS
German Title of Invention:
MONOKLONALE ANTIKÖRPER FÜR DIE TUMORBEHANDLUNG
SPC Number:

Dates

Filing date:
11/02/2009
Grant date:
14/06/2017
EP Publication Date:
27/10/2010
PCT Publication Date:
20/08/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2017
EP B1 Publication Date:
14/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/02/2018
Expiration date:
11/02/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/06/2017
 
 

Name:
Cure Tech Ltd.
Address:
Hayarkon Street 42, 81227 Yavne, Israel (IL)

Inventor

1

Name:
ROTEM-YEHUDAR, Rinat
Address:
Israel (IL)

2

Name:
RODIONOV, Galina
Address:
Israel (IL)

Priority

1

Priority Number:
27501 P
Priority Date:
11/02/2008
Priority Country:
United States (US)

2

Priority Number:
37340 P
Priority Date:
18/03/2008
Priority Country:
United States (US)

3

Priority Number:
116319 P
Priority Date:
20/11/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/282; A61K 31/337; A61K 31/513; A61K 31/7068; A61K 39/395; C07K 16/18; C07K 16/30;

Publication

European Patent Bulletin

Issue number:
201724
Publication date:
14/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages